CASP1 and COVID-19: Inflammatory mediators IL-1β and IL-18, the main cytokine products of caspase-1 activation, are observed to be increased in the lungs and sera of patients with symptomatic COVID-19 compared to asymptomatic patients and healthy individuals (82–84).